HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Improvement of the Clinical and Psychological Profile of Patients with Autism after Methylcobalamin Syrup Administration.

Abstract
(1) Background: Autism, also known as autism-spectrum disorder, is a pervasive developmental disorder affecting social skills and psychological status in particular. The complex etiopathogenesis of autism limits efficient therapy, which leads to problems with the normal social integration of the individual and causes severe family distress. Injectable methylcobalamin was shown to improve the clinical status of patients via enhanced cell oxidative status and/or methylation capacity. Here we tested the efficiency of a syrup form of methylcobalamin in treating autism. (2) Methods: Methylcobalamin was administered daily at 500 µg dose to autistic children and young adults (n = 25) during a 200-day period. Clinical and psychological status was evaluated by parents and psychologists and plasma levels of reduced and oxidized glutathione, vitamin B12, homocysteine, and cysteine were determined before the treatment, and at day 100 and day 200 of the treatment. (3) Results: Good patient compliance was reported. Methylcobalamin treatment gradually improved the overall clinical and psychological status, with the highest impact in the social domain, followed by the cognitive, behavioral and communication characteristics. Changes in the clinical and psychological status were strongly associated with the changes in the level of reduced glutathione and reduced/oxidized glutathione ratio. (4) Conclusion: A high dose of methylcobalamin administered in syrup form ameliorates the clinical and psychological status of autistic individuals, probably due to the improved oxidative status.
AuthorsAdela Čorejová, Tomáš Fazekaš, Daniela Jánošíková, Juraj Repiský, Veronika Pospíšilová, Maria Miková, Drahomíra Rauová, Daniela Ostatníková, Ján Kyselovič, Anna Hrabovská
JournalNutrients (Nutrients) Vol. 14 Issue 10 (May 12 2022) ISSN: 2072-6643 [Electronic] Switzerland
PMID35631176 (Publication Type: Journal Article)
Chemical References
  • mecobalamin
  • Vitamin B 12
  • Glutathione Disulfide
Topics
  • Adolescent
  • Autistic Disorder (drug therapy)
  • Child
  • Child, Preschool
  • Female
  • Glutathione Disulfide (blood)
  • Humans
  • Male
  • Vitamin B 12 (administration & dosage, analogs & derivatives)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: